Cell Secretome from Mesenchymal Stem Cells for Periodontal Regeneration DOI Creative Commons
Fuhua Yan, Xiao Yin, Bin Chen

и другие.

Regenerative medicine and dentistry., Год журнала: 2024, Номер unknown, С. 4 - 4

Опубликована: Дек. 23, 2024

Review Cell Secretome from Mesenchymal Stem Cells for Periodontal Regeneration Bin Chen 1,†, Lili Li Xiaoxin Zhang 2, Qing Liu 1, Yin Xiao 3,* and Fuhua Yan 1,* 1 Department of Periodontology, Nanjing Stomatological Hospital, Affiliated Hospital Medical School, Institute Stomatology, University, 210008, China 2 Central Laboratory 3 School Medicine Dentistry & Biomedicine Glycomics, Griffith Gold Coast, QLD 4222, Australia * Correspondence: [email protected] (Y.X.); [email protected] (F.Y.) † These authors contributed equally to this work. Received: 6 November 2024; Revised: 12 December Accepted: 16 Published: 23 2024 Abstract: Periodontitis affects approximately 50% the global adult population results in varying degrees periodontal destruction. The regeneration tissue is great demand but currently difficult achieve. cell secretome mesenchymal stem cells (CSmsc) has shown promise promoting a translational alternative (MSC)-based therapy. practical components CSmsc are soluble secretions extracellular vesicles. mechanisms CSmsc-induced may lie its regulation local microenvironment, modulating immune such as macrophages stimulating host MSCs, with direct effect on regeneration. Therefore, been suggested promising cell-based product future regenerative Hence, more studies should be conducted analyse effective MSC secretome, explore underlying mechanisms, obtain functional clinical translation

Язык: Английский

Understanding and controlling the variables for advanced cell therapy DOI Creative Commons

Naveen Jeyaraman,

Sandeep Shrivastava, Vangari Ravi

и другие.

World Journal of Stem Cells, Год журнала: 2024, Номер 16(8), С. 784 - 798

Опубликована: Авг. 26, 2024

In regenerative medicine, the isolation of mesenchymal stromal cells (MSCs) from adipose tissue’s vascular fraction (SVF) is a critical area study. Our review meticulously examines process MSCs, starting with extraction tissue. The choice liposuction technique, anatomical site, and immediate processing are essential to maintain cell functionality. We delve into intricacies enzymatic digestion, emphasizing fine-tuning enzyme concentrations maximize yield while preventing harm. then outlines filtration centrifugation techniques necessary for isolating purified SVF, alongside viability assessments like flow cytometry, which vital confirming efficacy isolated MSCs. discuss advantages drawbacks using autologous vs allogeneic SVF sources, touching upon immunocompatibility logistical considerations, as well variability inherent in donor-derived cells. Anesthesia choices, selection between hypodermic needles cannulas, role tissue lysers achieving cellular dissociation evaluated their impact on isolation. Centrifugation protocols also analyzed part ensuring integrity SVF. necessity standardized MSC highlighted, promoting reproducibility successful clinical application. encourage ongoing research deepen understanding biology therapeutic action, aiming further field medicine. concludes call rigorous research, interdisciplinary collaboration, strict adherence ethical regulatory standards safeguard patient safety optimize treatment outcomes

Язык: Английский

Процитировано

5

Enhancement of adipose stem cell quality via Cu‐MON: Transcriptome and bioinformatics analysis of normal and diabetic stem cells DOI Creative Commons

Richong Pang,

K. Liu,

Biou Liu

и другие.

FASEB BioAdvances, Год журнала: 2025, Номер unknown

Опубликована: Янв. 18, 2025

Abstract Transplanted adipose stem cells (ASC) have a low survival rate in the body, and there are not many ASC that can be effectively used, which weakens their tissue repair function. Based on this status quo, new type of copper‐based metal–organic network (Cu‐MON) was used to pretreat regulate cell activity order improve efficacy therapy or reduce number thus reducing cost clinical treatment. Gene expression changes before after Cu‐MON treatment normal donor (ND‐ASC) 2 diabetes mellitus (T2DM‐ASC) were evaluated through RNA sequencing, KEGG GO enrichment analysis. The results showed improved quality by regulating immune response promoting paracrine secretion. IL‐17 signaling pathway IL‐6, CXCL8, MMP‐9 key pathways necessary genes affected ability cells. In addition, also antiviral Type I interferon pathway. Our research had response, secretion, improving capabilities. This approach biomaterial pretreatment is fast, convenient, relatively safe, provides strategies for efficiency therapies.

Язык: Английский

Процитировано

0

Clinical research progress of umbilical cord blood mesenchymal stem cells in Knee articular cartilage repair: A review DOI Creative Commons
Zhongkai Liao

Medicine, Год журнала: 2025, Номер 104(6), С. e41402 - e41402

Опубликована: Фев. 7, 2025

Umbilical cord blood mesenchymal stem cells (UCB-MSCs) are a type of adult cell with multipotent differentiation potential and immunoregulatory functions, primarily found in neonatal blood. Due to their noninvasive collection method, abundance, ease preservation, UCB-MSCs represent promising biological material. This review examines the clinical research on knee articular cartilage repair, highlighting regenerative for treating joint defects. Our aim is provide insights into current applications propose directions future research, focusing optimizing use enhancing patient outcomes.

Язык: Английский

Процитировано

0

miRNA let-7f-5p-encapsulated labial gland MSC-derived EVs ameliorate experimental Sjögren’s syndrome by suppressing Th17 cells via targeting RORC/IL-17A signaling axis DOI Creative Commons

Yufei Xie,

Maosheng Chai,

Yixiao Xing

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Март 20, 2025

Sjögren's syndrome (SS) is an autoimmune disease primarily affecting salivary glands, with xerostomia as a distinct clinical manifestation. This also poses significantly increased risk of lymphoma, severely impacting patients' quality life. The imbalance between Th17 and Treg cells plays critical role in SS progression, driving severe immune dysregulation, chronic inflammation, escalating tissue dysfunction. However, current treatments for still remain limited, it continues to be recognized refractory disease. Therefore, the development novel effective therapeutic strategies pressing demand research. In recent years, extracellular vesicle (EV) therapy has emerged promising approach treatment, showing encouraging outcomes modulating balance alleviating symptoms. EVs carry diverse cargo, among which microRNAs (miRNAs) are highly abundant play roles. These small RNAs essential EV-mediated functions, particularly regulating gene expression microenvironment. Our research team first isolated labial gland mesenchymal stem (LGMSCs) their derived (LGMSC-EVs), offer potential advantages due origin. Then we screened identified enriched miRNA let-7f-5p key regulator through profiling analysis. To achieve better outcomes, transfected exogenous into LGMSC-EVs upregulate its expression, thereby constructing let-7f-5p-encapsulated LGMSC-EVs. modified were subsequently tested experimental mouse model evaluate potential. upregulation enhanced effects, resulting improvements such flow reduced lymphocytic infiltration. Mechanistically, suppressed by directly targeting 3'-untranslated region (3'UTR) RORC, inhibiting RORC/IL-17A signaling axis, reducing IL-17A production, restoring Th17/Treg promoting anti-inflammatory profile. Collectively, this LGMSC-EV offers target-driven treatment SS, achieving improved rebalance after modification let-7f-5p, presents new SS.

Язык: Английский

Процитировано

0

Cell membrane-coated nanoparticles: a biomimetic strategy for effective treatment of ischemic stroke DOI
M. Qi, Yanping Sun,

Zirui Zhao

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106966 - 106966

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Comparative breakthrough: Umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment DOI
Peng Li

World Journal of Cardiology, Год журнала: 2024, Номер 16(12), С. 776 - 780

Опубликована: Ноя. 25, 2024

In this article, we evaluate the comparative efficacy and safety of mesenchymal stem cells (MSCs) derived from bone marrow (BM-MSCs) umbilical cord (UC-MSCs) in treatment heart failure myocardial infarction. MSCs have gained importance as living bio drug due to their regenerative potential, with BM-MSCs being most extensively studied. However, UC-MSCs offer unique advantages, such noninvasive collection fewer ethical concerns. This systematic review meta-analysis summarizes data 13 randomized controlled trials, which included a total 693 patients. Their study shows that significantly improved left ventricular ejection fraction by 5.08% at 6 months 2.78% 12 compared controls, while showed no significant effect. Neither cell type changes 6-minute walk distance. addition, had comparable profiles, differences major adverse cardiac events, except for lower rehospitalization rate observed BM-MSCs. These results position promising alternative MSC-based therapies disease, offering potential improvements function maintaining favorable profile. Future research should focus on optimizing administration protocols further exploring long-term benefits mechanisms repair.

Язык: Английский

Процитировано

1

Dental Pulp-Derived Mesenchymal Stromal Cells DOI
Sibel Yıldırım

Springer eBooks, Год журнала: 2024, Номер unknown, С. 85 - 126

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0

Cell Secretome from Mesenchymal Stem Cells for Periodontal Regeneration DOI Creative Commons
Fuhua Yan, Xiao Yin, Bin Chen

и другие.

Regenerative medicine and dentistry., Год журнала: 2024, Номер unknown, С. 4 - 4

Опубликована: Дек. 23, 2024

Review Cell Secretome from Mesenchymal Stem Cells for Periodontal Regeneration Bin Chen 1,†, Lili Li Xiaoxin Zhang 2, Qing Liu 1, Yin Xiao 3,* and Fuhua Yan 1,* 1 Department of Periodontology, Nanjing Stomatological Hospital, Affiliated Hospital Medical School, Institute Stomatology, University, 210008, China 2 Central Laboratory 3 School Medicine Dentistry & Biomedicine Glycomics, Griffith Gold Coast, QLD 4222, Australia * Correspondence: [email protected] (Y.X.); [email protected] (F.Y.) † These authors contributed equally to this work. Received: 6 November 2024; Revised: 12 December Accepted: 16 Published: 23 2024 Abstract: Periodontitis affects approximately 50% the global adult population results in varying degrees periodontal destruction. The regeneration tissue is great demand but currently difficult achieve. cell secretome mesenchymal stem cells (CSmsc) has shown promise promoting a translational alternative (MSC)-based therapy. practical components CSmsc are soluble secretions extracellular vesicles. mechanisms CSmsc-induced may lie its regulation local microenvironment, modulating immune such as macrophages stimulating host MSCs, with direct effect on regeneration. Therefore, been suggested promising cell-based product future regenerative Hence, more studies should be conducted analyse effective MSC secretome, explore underlying mechanisms, obtain functional clinical translation

Язык: Английский

Процитировано

0